2016
DOI: 10.1016/j.drup.2016.06.003
|View full text |Cite
|
Sign up to set email alerts
|

Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
19
0
2

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 40 publications
(22 citation statements)
references
References 169 publications
(105 reference statements)
0
19
0
2
Order By: Relevance
“…The development of precision drug delivery systems with precisely controlled stability and programmed drug release property has enormous potential to reduce the toxicity of the drugs and enhance their therapeutic efficacy. It will greatly facilitate the application of precision medicine in oncology for better care of cancer patients 2 .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The development of precision drug delivery systems with precisely controlled stability and programmed drug release property has enormous potential to reduce the toxicity of the drugs and enhance their therapeutic efficacy. It will greatly facilitate the application of precision medicine in oncology for better care of cancer patients 2 .…”
Section: Introductionmentioning
confidence: 99%
“…Due to their superior biocompatibility, relatively smaller diameter (10–100 nm) and high capacity to encapsulate hydrophobic drugs, micellar nanoparticles are ideal candidates for the development of precision drug delivery systems 221 . Furthermore, recent advancement in materials sciences and nanotechnology has led to the creation of a new generation of such nanoparticles called stimuli-responsive cross-linked micellar nanoparticles (SCMNs).…”
Section: Introductionmentioning
confidence: 99%
“…Their ultimate goal is to image and characterize the molecular profile of a disease, to follow in vivo drug delivery and drug efficacy in the hope of adapting the most tailored therapy and dose to each individual patient. Theranostics are often associated with nanomedicine as it is relatively straightforward to load nanoparticles simultaneously with therapeutic drugs and imaging probes to provide imaging and therapeutic capabilities within a single agent . In contrast, small‐molecule theranostic agents hold promise for easier characterization and better control of the physical‐chemical properties.…”
Section: Introductionmentioning
confidence: 99%
“…Theranostics are often associated with nanomedicine as it is relatively straightforward to load nanoparticles simultaneously with therapeutic drugs and imaging probes to providei maging and therapeutic capabilities within as ingle agent. [7] In contrast, small-moleculet heranostic agents hold promise for easier characterization and better control of the physical-chemical properties. Gd 3 + complexes combinedw ith therapeutic approaches have been widely investigated in this context,b oth in the class of nanoparticles and molecular probes.…”
Section: Introductionmentioning
confidence: 99%
“…Multifunctional nanoparticles that label tumours for additional imaging have been increasingly introduced in the field of oncology research [10]. These nanoparticles are usually coupled with targeting ligands such as antibodies for cancer biomarker targeting [11].…”
Section: Introductionmentioning
confidence: 99%